Bill Nelson on Health Care Democratic Sr Senator (FL)

COVID: wearing a mask must not be a partisan issue

Medicaid expansion is difference between life or death

Gator Aid: $2.5B Medicare funding in ObamaCare

• The Louisiana Purchase: Sen. Landrieu was promised an additional $300 million in Medicaid funding for Louisiana.
• The Cornhusker Kickback: Sen. Ben Nelson secured exemptions for Nebraska's Medicaid payments worth around $100 million.
• The U-Con: Sen. Dodd was promised $100 million for a medical center in CT.
• Gator Aid: Sen. Bill Nelson inserted a grandfather clause that would protect Florida's Medicare Advantage program, a $2.5-$3 billion buyoff.

Supports More Federal Funding for Health Coverage

Establish "report cards" on HMO quality of care.

Promote Universal Access and Quality in Health Care
That more than 40 million Americans lack health insurance is one of our society’s most glaring inequities. Lack of insurance jeopardizes the health of disadvantaged Americans and also imposes high costs on everyone else when the uninsured lack preventive care and get treatment from emergency rooms. Washington provides a tax subsidy for insurance for Americans who get coverage from their employers but offers nothing to workers who don’t have job-based coverage.

Markets alone cannot assure universal access to health coverage. Government should enable all low-income families to buy health insurance. Individuals must take responsibility for insuring themselves and their families whether or not they qualify for public assistance.

Finally, to help promote higher quality in health care for all Americans, we need reliable information on the quality of health care delivered by health plans and providers; a “patient’s bill of rights” that ensures access to medically necessary care; and a system in which private health plans compete on the basis of quality as well as cost.

Goals for 2010
• Reduce the number of uninsured Americans by two-thirds through tax credits, purchasing pools, and other means.
• Create a system of reliable “report cards” on the quality of care delivered by health plans and providers.

Rated 100% by APHA, indicating a pro-public health record.

The American Public Health Association (APHA) is the oldest and largest organization of public health professionals in the world, representing more than 50,000 members from over 50 occupations of public health. APHA is concerned with a broad set of issues affecting personal and environmental health, including federal and state funding for health programs, pollution control, programs and policies related to chronic and infectious diseases, a smoke-free society, and professional education in public health.

The following ratings are based on the votes the organization considered most important; the numbers reflect the percentage of time the representative voted the organization`s preferred position.

Merge Alzheimers diagnosis and care benefit.

Congressional Summary:The purpose of this Act is to increase diagnosis of Alzheimer`s disease and related dementias, leading to better care and outcomes for Americans living with Alzheimer`s disease and related dementias. Congress makes the following findings:

1. As many as half of the estimated 5.2 million Americans with Alzheimer`s disease have never received a diagnosis.
2. An early and documented diagnosis and access to care planning services leads to better outcomes for individuals with Alzheimer`s disease.
3. Combining the existing Medicare benefits of a diagnostic evaluation and care planning into a single package of services would help ensure that individuals receive an appropriate diagnosis as well as critical information about the disease and available care options.

Proponent`s argument for bill: (The Alzheimer`s Association, alz.org). The `Health Outcomes, Planning, and Education (HOPE) for Alzheimer`s Act` (S.709/H.R. 1507) is one of the Alzheimer`s Association`s top federal priorities for the 113th Congress. The HOPE for Alzheimer`s Act would improve diagnosis of Alzheimer`s diseas

Keep healthcare mandate, according to CC survey.

The Christian Coalition Voter Guide inferred whether candidates agree or disagree with the statement, 'Repealing the Nationalized Health Care System that Forces Citizens to Buy Insurance ' Christian Coalition's self-description: "Christian Voter Guide is a clearing-house for traditional, pro-family voter guides. We do not create voter guides, nor do we interview or endorse candidates."

Preserve access to Medicaid & SCHIP during economic downturn.

A bill to preserve access to Medicaid and the State Children`s Health Insurance Program during an economic downturn.

• Economic Recovery in Health Care Act of 2008 - Prohibits finalizing, implementing, enforcing, or otherwise taking any action, prior to April 1, 2009, on any changes to Medicaid programs or State Children`s Health Insurance Program (SCHIP).
• Amends the U.S. Troop Readiness, Veterans` Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007 to extend through April 1, 2009, the moratorium relating to the cost limit for providers.
• Amends the Medicare, Medicaid, and SCHIP Extension Act of 2007 to extend through April 1, 2009, the moratorium relating to rehabilitation services, school-based administration, and school-based transportation.
• Provides for state fiscal relief through a temporary increase of Medicaid federal medical assistance percentage (FMAP).

Establishment of Office of Health Care Fraud Prevention.

CONGRESSIONAL SUMMARY:
• There is hereby established, in the Department of H, the Office of the Deputy Secretary for Health Care Fraud Prevention.
• The Office shall provide contracts for the design, development, and operation of a predictive model antifraud system, based on the risk level assigned to claims activity, and develop a comprehensive antifraud database for health care activities carried out or managed by Federal health agencies.
• The Office shall promulgate and enforce regulations relating to the reporting of data claims to the health care antifraud system.

SPONSOR`S INTRODUCTORY REMARKS:

Sen. LeMIEUX. The current proposal for health care is a $1 trillion proposal. If we spent as much time caring about the money we are spending now, as opposed to the money some in this Chamber want to spend, I suspect we could find plenty of money to either return to the people or to find money for these new programs.

Today, I wish to talk about just such an idea, an idea to recover some of the waste, fraud, and abuse that is currently happening in our current provision of health care--in Medicare and Medicaid. Estimates are that some $60 billion to a staggering $226 billion a year to waste, fraud, and abuse.

This health care proposal that we are discussing in the Senate is $1 trillion over 10 years. That is about $100 billion a year. We may be wasting $226 billion a year. If we captured just half of that, we might be able to pay for this program.

Why can`t we do the same thing the credit card companies are doing for health care? Why can`t we use a predictive modeling system that says a health care claim is not going to be paid when a red flag comes up? Right now we are on a pay-and-chase system. If we put this predictive modeling system in, it stops the fraud before it happens. The credit card industry benchmark is 0.1% while fraud losses in the health care business run from 3% to 14%.

Expedited licensing for biosimilar products.

Amends the Public Health Service Act to provide for the licensing of biosimilar and interchangeable biological products.
• Allows any person to file an abbreviated biological product application with the Secretary of Health and Human Services. Requires such applications to include information demonstrating a high degree of similarity or interchangeability between the biological product and the licensed biological product (reference product).
• Requires the Secretary to:
  1. approve an application and issue a license for a biosimilar product unless the Secretary finds and informs the applicant that the information in the application fails to demonstrate biosimilarity between the biological product and the reference product or the safety, purity, and potency of the biological product; and
  2. establish requirements for the efficient review, approval, suspension, and revocation of abbreviated biological product applications.
• Allows an applicant a determination as to the interchangeability of a product and its reference product based on whether a product can be expected to produce the same clinical result as the reference product in any given patient. Grants market exclusivity to any biological product that is determined to be interchangeable for a specified period.
• Sets forth provisions governing patent infringement claims involving comparable biological products and legal remedies to expedite the adjudication of patent infringement disputes.
• Extends the period for approval of biological products to allow for studies of the use of new biological products in the pediatric population.